ID
34757
Description
A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes in Patients With High Baseline HbA1c; ODM derived from: https://clinicaltrials.gov/show/NCT01785771
Lien
https://clinicaltrials.gov/show/NCT01785771
Mots-clés
Versions (1)
- 27/01/2019 27/01/2019 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
27 janvier 2019
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Type 2 Diabetes NCT01785771
Eligibility Type 2 Diabetes NCT01785771
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
GLP-1 Receptor Agonist
Type de données
boolean
Alias
- UMLS CUI [1]
- C2917359
Description
Hypersensitivity Exenatide | Hypersensitivity Liraglutide
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0020517
- UMLS CUI [1,2]
- C0167117
- UMLS CUI [2,1]
- C0020517
- UMLS CUI [2,2]
- C1456408
Description
Plasma fasting glucose measurement
Type de données
boolean
Alias
- UMLS CUI [1]
- C0583513
Description
Medullary carcinoma of thyroid | Multiple Endocrine Neoplasia Type | Family history of multiple endocrine neoplasia Type
Type de données
boolean
Alias
- UMLS CUI [1]
- C0238462
- UMLS CUI [2,1]
- C0027662
- UMLS CUI [2,2]
- C0332307
- UMLS CUI [3,1]
- C4039247
- UMLS CUI [3,2]
- C0332307
Description
Dipeptidyl-Peptidase IV Inhibitors | Incretin mimetic product | alpha-Glucosidase Inhibitors | Meglitinide | Insulin
Type de données
boolean
Alias
- UMLS CUI [1]
- C1827106
- UMLS CUI [2]
- C1562104
- UMLS CUI [3]
- C1299007
- UMLS CUI [4]
- C0065880
- UMLS CUI [5]
- C0021641
Description
Pancreatitis
Type de données
boolean
Alias
- UMLS CUI [1]
- C0030305
Similar models
Eligibility Type 2 Diabetes NCT01785771
- StudyEvent: Eligibility
C0011860 (UMLS CUI [2])
C0015259 (UMLS CUI [2])
C0009429 (UMLS CUI [3])
C0025598 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
C0038766 (UMLS CUI [5,1])
C0178602 (UMLS CUI [5,2])
C0205360 (UMLS CUI [5,3])
C1257987 (UMLS CUI [6,1])
C0178602 (UMLS CUI [6,2])
C0205360 (UMLS CUI [6,3])
C0167117 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1456408 (UMLS CUI [2,2])
C0027662 (UMLS CUI [2,1])
C0332307 (UMLS CUI [2,2])
C4039247 (UMLS CUI [3,1])
C0332307 (UMLS CUI [3,2])
C1562104 (UMLS CUI [2])
C1299007 (UMLS CUI [3])
C0065880 (UMLS CUI [4])
C0021641 (UMLS CUI [5])